<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis</h1>
  <ul>
<li>2021.</li>
<li>2024;25(3):463.</li>
<li>2011;41:112-124.</li>
<li>Epub 2024 Jan 18.</li>
<li>Epub 2011 May 12.</li>
<li>2024;25(3):447-461.</li>
<li>2021 Jun 11;10(12):2578.</li>
</ul>
<p><a href="https://finance.yahoo.com/news/amgen-kyowa-kirin-announce-top-041200878.html">Source</a> · 2025-09-09T04:12:00+00:00</p>
</body>
</html>